IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,126,396 | -29.4% | 1,016,156 | -16.0% | 0.30% | -24.2% |
Q2 2023 | $22,831,247 | +348.2% | 1,209,923 | -8.8% | 0.40% | +280.8% |
Q1 2023 | $5,093,679 | -23.0% | 1,326,479 | -0.5% | 0.10% | -27.8% |
Q4 2022 | $6,614,448 | +2.6% | 1,333,558 | -1.1% | 0.14% | -2.7% |
Q3 2022 | $6,448,000 | +3.1% | 1,348,963 | -3.0% | 0.15% | +8.8% |
Q2 2022 | $6,257,000 | -6.4% | 1,390,532 | -1.0% | 0.14% | +15.3% |
Q1 2022 | $6,686,000 | -24.0% | 1,404,668 | +18.4% | 0.12% | -22.4% |
Q4 2021 | $8,801,000 | +80.1% | 1,186,058 | +37.6% | 0.15% | +68.9% |
Q3 2021 | $4,887,000 | -16.8% | 861,882 | -3.3% | 0.09% | -15.1% |
Q2 2021 | $5,876,000 | -17.4% | 891,727 | +1.6% | 0.11% | -22.1% |
Q1 2021 | $7,112,000 | +13.1% | 878,058 | -10.0% | 0.14% | +6.2% |
Q4 2020 | $6,291,000 | +67.9% | 975,418 | -6.2% | 0.13% | +43.8% |
Q3 2020 | $3,746,000 | -25.1% | 1,040,431 | -4.3% | 0.09% | -27.6% |
Q2 2020 | $5,000,000 | +33.5% | 1,087,034 | -1.0% | 0.12% | +7.9% |
Q1 2020 | $3,744,000 | -42.3% | 1,098,005 | -13.6% | 0.11% | -19.7% |
Q4 2019 | $6,489,000 | +97.4% | 1,271,187 | -6.4% | 0.14% | +84.4% |
Q3 2019 | $3,287,000 | +5.2% | 1,358,127 | -5.7% | 0.08% | +5.5% |
Q2 2019 | $3,125,000 | -28.3% | 1,439,865 | -10.4% | 0.07% | -25.5% |
Q1 2019 | $4,357,000 | -0.1% | 1,607,596 | +76.9% | 0.10% | -13.3% |
Q4 2018 | $4,362,000 | -51.1% | 908,776 | -3.5% | 0.11% | -38.9% |
Q3 2018 | $8,922,000 | -16.4% | 942,180 | -14.1% | 0.18% | -15.9% |
Q2 2018 | $10,673,000 | -20.0% | 1,096,937 | -13.5% | 0.22% | -15.7% |
Q1 2018 | $13,334,000 | +57.3% | 1,267,507 | -4.1% | 0.26% | +60.1% |
Q4 2017 | $8,476,000 | -24.5% | 1,322,231 | -9.8% | 0.16% | -21.3% |
Q3 2017 | $11,220,000 | +4.0% | 1,466,679 | -3.4% | 0.21% | 0.0% |
Q2 2017 | $10,790,000 | +75.4% | 1,517,639 | -4.5% | 0.21% | +75.4% |
Q1 2017 | $6,153,000 | +85.8% | 1,589,959 | -2.0% | 0.12% | +76.1% |
Q4 2016 | $3,311,000 | -29.0% | 1,623,124 | -6.7% | 0.07% | -28.0% |
Q3 2016 | $4,661,000 | -14.3% | 1,739,176 | -1.5% | 0.09% | -20.5% |
Q2 2016 | $5,439,000 | -65.1% | 1,766,046 | -3.5% | 0.12% | -65.0% |
Q1 2016 | $15,600,000 | -35.0% | 1,830,939 | +3.5% | 0.33% | -33.6% |
Q4 2015 | $23,997,000 | +104.5% | 1,768,359 | +44.6% | 0.50% | +93.5% |
Q3 2015 | $11,737,000 | -35.3% | 1,222,575 | -3.1% | 0.26% | -22.8% |
Q2 2015 | $18,138,000 | +59.4% | 1,261,320 | -0.8% | 0.34% | +59.0% |
Q1 2015 | $11,381,000 | +50.6% | 1,271,640 | +2.6% | 0.21% | +43.2% |
Q4 2014 | $7,558,000 | -42.3% | 1,239,092 | +0.3% | 0.15% | -44.4% |
Q3 2014 | $13,088,000 | +31.9% | 1,235,862 | +47.6% | 0.27% | +37.1% |
Q2 2014 | $9,923,000 | -24.8% | 837,357 | -5.2% | 0.19% | -24.5% |
Q1 2014 | $13,193,000 | -2.4% | 883,647 | -4.1% | 0.26% | -2.7% |
Q4 2013 | $13,513,000 | -15.6% | 921,157 | -2.1% | 0.26% | -20.2% |
Q3 2013 | $16,013,000 | +1.7% | 940,853 | -0.9% | 0.33% | -6.5% |
Q2 2013 | $15,753,000 | – | 949,575 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |